Case Studies

  1. Strengthening cIEF Method Validation With cIEF-MS 8/14/2026

    Preparing for method validation, a biopharma company needed to characterize cIEF charge variants and confirm peak identities for regulatory readiness.

  2. Confirming Structural Consistency With HDX-MS 8/14/2026

    To support regulatory confidence, a biopharma company evaluated whether manufacturing changes affected its monoclonal antibody's higher-order structure.

  3. Confident Sialic Acid Identification With MS/MS 8/14/2026

    Traditional mass spectrometry left uncertainty around potentially immunogenic glycans. Learn how a biologics developer achieved regulatory-ready clarity.

  4. Building A Smarter Potency Strategy For Bispecific Antibodies 8/14/2026

    A biotech company needed a regulatory-ready potency strategy for a bispecific antibody. This organization combined orthogonal analytics with functional assays.

  5. Developing A Robust Crystallization Process For A High-Molecular-Weight Peptide 8/14/2026

    Scaling peptide crystallization is complex, with solid forms, polymorphic impurities, and solvent constraints all impacting quality and manufacturability.

  6. Characterizing AAV Payload With GMP-Compliant svAUC 8/14/2026

    Ensuring AAV quality starts with payload characterization. Learn why conventional methods may miss key capsid population insights.

  7. Revealing Hidden Integration Events With TLA And Nanopore Sequencing 8/14/2026

    When standard methods fell short, a biotech company used advanced analysis to confirm targeted construct integration and detect hidden genome changes.

  8. From Variability To Validation – GMP Bioassay Success Through Partnership 2/27/2026

    Turn your inconsistent bioassays into GMP-validated, high-reliability platforms — just like we helped a biopharma partner cut failure rates from ~25% to <1%.

  9. Case Study: The Right Ratio – Building An End-To-End DAR Strategy For ADC Success 2/27/2026

    When developing antibody-drug conjugates (ADCs), a robust drug-to-antibody ration (DAR) strategy isn’t just nice to have — it's mission-critical.

  10. Case Study: Full Clonality Assessment Of CHO Cell Line 2/27/2026

    In this case study, a comprehensive genetic analysis was performed on a transgenic Chinese hamster ovary (CHO) master cell bank to characterize the bank and provide high-confidence evidence of clonality.